Corticosteroid therapy for patients with HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count);Corticoterapia na síndrome de HELLP (hemólise, enzimas hepáticos elevados e trombocitopenia)

Acta Medica Portuguesa

Volumn 18, Issue 3, 2005, Pages 177-182

  Nunes, Filomena ^a   Campos, Ana Paula ^a   Avillez, Teresa ^a   Rodrigues, Rosalinda ^a   Meirinho, Manuel ^a  

^a HOSPITAL GARCIA DE ORTA   (Portugal)

Author keywords

Corticosteroids; Dexamethasone; HELLP syndrome; Regional anaesthesia; Severe preeclampsia

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CORTICOSTEROID; DEXAMETHASONE; LACTATE DEHYDROGENASE; LIVER ENZYME;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANESTHESIOLOGICAL TECHNIQUES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TRANSFUSION; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DELIVERY; DRUG MEGADOSE; EPIGASTRIC PAIN; FEMALE; FETUS LUNG MATURATION; HELLP SYNDROME; HEMOLYSIS; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; MATERNAL MORBIDITY; OBSTETRIC ANESTHESIA; PERINATAL MORTALITY; PREECLAMPSIA; PREMATURITY; REGIONAL ANESTHESIA; REVIEW; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HELLP SYNDROME; HUMANS; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 22044435283     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. The American College of Obstetricians and Gynecologists: Hypertension in pregnancy. Washington: The College; 1996 ACOG Technical Bulletin n°: 219
2. THIAGARAJAH S, BOURGEOIS FJ, HARBERT GM Jr, CAUDLE MR: Thrombocytopenia in preeclampsia: associated abnormalities and management principle. Am J Obstet Gynecol 1984; 150:1-7
3. GEARY M: The HELLP Syndrome: Br J Obstet Gynaecol 1997; 104:887-91
4. ROMERO R, MAZOR M, LOCKWOOD CJ et al: Clinical significance, prevalence, and natural history of thrombocytopenia in pregnancy-induced hypertension. Am J Perinatol 1989; 6:32-8.
5. PRITCHARD JA, WEISSMAN R, RATNOFF OD et al: Intravascular hemolysis, thrombocytopenia and other hematologic abnormalities associated with severe toxemia of pregnancy. N Engl J Med 1954; 250:89-98
6. WEINSTEIN L: Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142:159-67
7. MARTIN JN Jr, BLAKE PG, PERRY KG Jr et al: The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol 1991; 164:1500-13
8. HEYBORNE KD, BURKE MS, PORRECO RP: Prolongation of premature gestation in women with hemolysis, elevated liver enzymes and low platelets. J Reprod Mod 1990;35:53-7
9. MAGANN EF, BASS D, CHAUHAN SP, SULLIVAN DL, MARTIN RW, MARTIN JN Jr: Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994; 171:1148-53
10. TOMPKINS MJ, THIAGARAJAH S: HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids. Am J Obst Gynecol 1999; 181: 304-9
11. MAGANN EF, PERRY KG Jr, MEYDRECH EF, HARRIS RL, CHAUHAN SP, MARTIN JN Jr: Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP). Am J Obstet Gynecol 1994; 171:1154-8
12. O'BRIEN JM, MILLIGAN DA, BARTON JR: Impact of high dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2000; 183: 921-4
13. MARTIN JN Jr, PERRY KG Jr, BLAKE PG, MAY WA, MOORE A, ROBINETTE L: Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome. Am J Obstet Gynecol 1997; 177:1011-7
14. SIBAI BM, TASLIMI MM, EL-NAZER A, AMON E, MABIE BC, RYAN GM: Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986; 155:501-9
15. VISSER W, WALLENBURG HC: Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe pre-eclampsia remote from term. Eur J Obstet Gynecol Reprod Biol 1995, 63: 147-54
16. ISLER CM, RINEHART BK, TERRONE DA, MARTIN RW, MAGANN EF, MARTIN JN Jr: Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1999; 181:924-8
17. MARTIN JN Jr, RINEHART BK, MAY WL, MAGANN EF, TERRONE DA, BLAKE PG: The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999; 180: 1373-84.
18. CHAMBERS JC, FUSI L, MALIK IS, HASKARD DO, DE SWIET M, KOONER JS: Association of maternal endothelial dysfunction with preeclampsia. JAMA 2001; 285:1607-12